Peisheng Xu

Title
InstitutionMedical University of South Carolina
DepartmentSCCP Pharmaceutical and Biomedical Sciences - USC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Liu HJ, Xu P. Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor. Adv Drug Deliv Rev. 2022 Dec; 191:114619. PMID: 36372301; PMCID: PMC9724744.
      Citations: 1     Fields:    Translation:Humans
    2. Soni M, Saatci O, Gupta G, Patel Y, Keerthi Raja MR, Li J, Liu X, Xu P, Wang H, Fan D, Sahin O, Chen H, Soni M, Saatci O, Gupta G, Patel Y, Keerthi Raja MR, Li J, Liu X, Xu P, Wang H, Fan D, Sahin O, Chen H. miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer. Int J Mol Sci. 2022 Jul 22; 23(15). PMID: 35897675; PMCID: PMC9331933.
      Citations: 1     Fields:    Translation:HumansCells
    3. Liu HJ, Wang M, Shi S, Hu X, Xu P, Liu HJ, Wang M, Shi S, Hu X, Xu P. A Therapeutic Sheep in Metastatic Wolf's Clothing: Trojan Horse Approach for Cancer Brain Metastases Treatment. Nanomicro Lett. 2022 Apr 28; 14(1):114. PMID: 35482117; PMCID: PMC9050993.
      Citations: 1     
    4. Sui B, Cheng C, Shi S, Wang M, Xu P, Sui B, Cheng C, Shi S, Wang M, Xu P. Esterase-activatable and GSH-responsive Triptolide Nano-prodrug for the Eradication of Pancreatic Cancer. Adv Nanobiomed Res. 2021 Nov; 1(11). PMID: 34870282; PMCID: PMC8635305.
      Citations:    
    5. Sui B, Wang M, Cheng C, Zhang Q, Zhang J, Fan D, Xu P, Sui B, Wang M, Cheng C, Zhang Q, Zhang J, Fan D, Xu P. Nanogel-facilitated Protein Intracellular Specific Degradation through Trim-Away. Adv Funct Mater. 2021 Jul 23; 31(30). PMID: 34421476; PMCID: PMC8376022.
      Citations:    
    6. Zhang Z, Wang X, Wei X, Zheng SW, Lenhart BJ, Xu P, Li J, Pan J, Albrecht H, Liu C, Zhang Z, Wang X, Wei X, Zheng SW, Lenhart BJ, Xu P, Li J, Pan J, Albrecht H, Liu C. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing. Biosens Bioelectron. 2021 Jun 01; 181:113134. PMID: 33761415; PMCID: PMC7927651.
      Citations:    
    7. Orr RK, Hoehn JL, Col NF, Cheng B, Xu P. Redox-Sensitive Nanocomplex for Targeted Delivery of Melittin. Toxins (Basel). 2020 09 10; 12(9). PMID: 32927695; PMCID: PMC7550998.
      Citations:    
    8. Cheng C, Sui B, Wang M, Hu X, Shi S, Xu P, Cheng C, Sui B, Wang M, Hu X, Shi S, Xu P. Carrier-Free Nanoassembly of Curcumin-Erlotinib Conjugate for Cancer Targeted Therapy. Adv Healthc Mater. 2020 10; 9(19):e2001128. PMID: 32893507; PMCID: PMC7593849.
      Citations:    
    9. Liu HJ, Wang M, Hu X, Shi S, Xu P, Liu HJ, Wang M, Hu X, Shi S, Xu P. Enhanced Photothermal Therapy through the In Situ Activation of a Temperature and Redox Dual-Sensitive Nanoreservoir of Triptolide. Small. 2020 09; 16(38):e2003398. PMID: 32797711; PMCID: PMC7983299.
      Citations:    
    10. Liu Q, Hodge J, Wang J, Wang Y, Wang L, Singh U, Li Y, Yao Y, Wang D, Ai W, Nagarkatti P, Chen H, Xu P, Murphy EA, Fan D, Liu Q, Hodge J, Wang J, Wang Y, Wang L, Singh U, Li Y, Yao Y, Wang D, Ai W, Nagarkatti P, Chen H, Xu P, Murphy EA, Fan D. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation. Theranostics. 2020; 10(18):8365-8381. PMID: 32724475; PMCID: PMC7381725.
      Citations:    
    11. He H, Nieminen AL, Xu P, He H, Nieminen AL, Xu P. A bioactivatable self-quenched nanogel for targeted photodynamic therapy. Biomater Sci. 2019 Dec 01; 7(12):5143-5149. PMID: 31577285; PMCID: PMC6864251.
      Citations:    
    12. Sui B, Cheng C, Wang M, Hopkins E, Xu P, Sui B, Cheng C, Wang M, Hopkins E, Xu P. Heterotargeted Nanococktail with Traceless Linkers for Eradicating Cancer. Adv Funct Mater. 2019 Dec 12; 29(50). PMID: 33041742; PMCID: PMC7546548.
      Citations:    
    13. Liu HJ, Xu P, Liu HJ, Xu P. Smart Mesoporous Silica Nanoparticles for Protein Delivery. Nanomaterials (Basel). 2019 Apr 02; 9(4). PMID: 30986952; PMCID: PMC6523670.
      Citations:    
    14. Cheng B, Gao F, Maissy E, Xu P, Cheng B, Gao F, Maissy E, Xu P. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles. Acta Biomater. 2019 01 15; 84:378-390. PMID: 30528604; PMCID: PMC6362832.
      Citations:    
    15. Soni M, Patel Y, Markoutsa E, Jie C, Liu S, Xu P, Chen H, Soni M, Patel Y, Markoutsa E, Jie C, Liu S, Xu P, Chen H. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer. Mol Cancer Res. 2018 09; 16(9):1348-1360. PMID: 29784669; PMCID: PMC6843115.
      Citations:    
    16. He H, Markoutsa E, Li J, Xu P, He H, Markoutsa E, Li J, Xu P. Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly. Acta Biomater. 2018 03 01; 68:113-124. PMID: 29294377; PMCID: PMC5803356.
      Citations:    
    17. He H, Markoutsa E, Zhan Y, Zhang J, Xu P, He H, Markoutsa E, Zhan Y, Zhang J, Xu P. Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy. Acta Biomater. 2017 09 01; 59:181-191. PMID: 28688985; PMCID: PMC5551691.
      Citations:    
    18. Markoutsa E, Xu P, Markoutsa E, Xu P. Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival. Mol Pharm. 2017 05 01; 14(5):1591-1600. PMID: 28335600; PMCID: PMC5534351.
      Citations:    
    19. Cheng B, Xu P, Cheng B, Xu P. Fabrication of Photothermal Stable Gold Nanosphere/Mesoporous Silica Hybrid Nanoparticle Responsive to Near-Infrared Light. Methods Mol Biol. 2017; 1530:117-123. PMID: 28150199.
      Citations:    
    20. Patel Y, Shah N, Lee JS, Markoutsa E, Jie C, Liu S, Botbyl R, Reisman D, Xu P, Chen H, Patel Y, Shah N, Lee JS, Markoutsa E, Jie C, Liu S, Botbyl R, Reisman D, Xu P, Chen H. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth. Oncotarget. 2016 Apr 05; 7(14):18295-308. PMID: 26918448; PMCID: PMC4951289.
      Citations:    
    21. He H, Altomare D, Ozer U, Xu H, Creek K, Chen H, Xu P, He H, Altomare D, Ozer U, Xu H, Creek K, Chen H, Xu P. Cancer cell-selective killing polymer/copper combination. Biomater Sci. 2016 Jan; 4(1):115-20. PMID: 26568413; PMCID: PMC4679545.
      Citations:    
    22. He H, Cattran AW, Nguyen T, Nieminen AL, Xu P, He H, Cattran AW, Nguyen T, Nieminen AL, Xu P. Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery. Biomaterials. 2014 Nov; 35(35):9546-53. PMID: 25154666; PMCID: PMC4157076.
      Citations:    
    23. Remant BK, Chandrashekaran V, Cheng B, Chen H, Peña MM, Zhang J, Montgomery J, Xu P, Remant BK, Chandrashekaran V, Cheng B, Chen H, Pe?a MM, Zhang J, Montgomery J, Xu P. Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells. Mol Pharm. 2014 Jun 02; 11(6):1897-905. PMID: 24779647; PMCID: PMC4334268.
      Citations:    
    24. Bahadur K C R, Xu P, Bahadur K C R, Xu P. Multicompartment intracellular self-expanding nanogel for targeted delivery of drug cocktail. Adv Mater. 2012 Dec 18; 24(48):6479-83. PMID: 23001909.
      Citations:    
    25. K C RB, Thapa B, Xu P, K C RB, Thapa B, Xu P. pH and redox dual responsive nanoparticle for nuclear targeted drug delivery. Mol Pharm. 2012 Sep 04; 9(9):2719-29. PMID: 22876763.
      Citations:    
    26. Bahadur K C R, Thapa B, Xu P, Bahadur K C R, Thapa B, Xu P. Design of serum compatible tetrary complexes for gene delivery. Macromol Biosci. 2012 May; 12(5):637-46. PMID: 22508502.
      Citations:    
    Xu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (172)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _